Please do not leave this page until complete. This can take a few moments.
Melinta Therapeutics announced this week that its partner is seeking permission to sell the firm’s successful antibiotic delafloxacin in Europe.
The medication, used to treat severe skin infections, including MRSA (Methicillin-resistant Staphylococcus aureus), is already marketed in the United States under the name Baxdela. If approved by regulators, the drug would be branded Quofenix in Europe, the New Haven-based company said.
“This is an important milestone for Melinta and, if approved, would represent a significant expansion of delafloxacin’s market reach,” Melinta CEO Dan Wechsler said.
The Menarini Group, Melinta’s commercial and development partner, submitted the application to the European Medicines Agency, according to the company. The request is based on two studies that meet U.S. Food and Drug Administration and EMA approval criteria, the firm said.
Under a 2017 agreement, Menarini has exclusive rights to market delafloxacin in 68 countries in Europe and the Asia-Pacific region, including China, Russia, South Korea and Australia.
Delafloxacin treats Acute Bacterial Skin and Skin Structure Infections, also known as ABSSSI.
Christopher Hoffman can be reached at news@newhavenbiz.com
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
Read HereThis special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments